Survival From Liver Cancer
Rarer Cancers Forum Pleads With NICE to Fund Liver Cancer Patients With Their Only Survival Option
NICE will convene today after two years of delays, to exercise their final opportunity to reverse the fate of thousands of UK advanced primary liver cancer patients who were told in November that they will be denied their only survival option, Nexavar on the NHS.
Liver Cancer
Themocracy